Evogene Ltd. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
EVGN Nasdaq 2830 www.evogene.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Evogene Ltd.

Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward - Aug 31st, 2026 6:00 am
EverGen Infrastructure Reports Q2 2026 Results - Aug 26th, 2026 10:26 pm
EverGen Infrastructure Announces Voting Results for the Annual General Meeting of Shareholders Held on August 25, 2026 - Aug 26th, 2026 3:00 pm
Evogene (EVGN) Q2 2026 Earnings Call Transcript - Aug 25th, 2026 5:45 am
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees - Aug 25th, 2026 5:00 am
Evogene Ltd. Q2 2026 Earnings Call Summary - Aug 19th, 2026 6:30 am
Evogene Ltd (EVGN) (Q2 2026) Earnings Call Highlights: Strategic Pivot to AI-Driven Drug ... - Aug 18th, 2026 3:01 pm
Evogene Reports Second Quarter and First Half 2026 Financial Results - Aug 18th, 2026 6:04 am
Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth – Quarterly Update Report - Aug 17th, 2026 3:50 pm
Freightos Appoints Yaron Eldad as Chief Financial Officer - Aug 17th, 2026 4:50 am
Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation - Aug 14th, 2026 5:00 am
Evogene Schedules Second Quarter 2026 Financial Results Release - Jul 30th, 2026 5:00 am
Evogene and ELEO to develop new oral PCSK9 inhibitors - Jul 23rd, 2026 4:06 am
Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases - Jul 22nd, 2026 6:00 am
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection - Jul 21st, 2026 2:31 pm
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection – Downloadable Initiation Report - Jul 21st, 2026 2:27 pm
AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag™ Capabilities - Jul 15th, 2026 5:30 am
EverGen Infrastructure Announces Record RNG Production for Q2 2026 - Jul 14th, 2026 2:05 pm
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery - Jul 8th, 2026 5:00 am
EverGen Infrastructure Announces Share Issuance to Officers and Directors of the Company - Jul 6th, 2026 9:00 pm